Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
C Minor has demonstrated a consistent presence in the Ontario market, particularly within the Capsules category. Starting the year at an 11th place ranking, the brand saw a slight decline, settling at 13th by April 2026. This decline is mirrored by a gradual decrease in sales figures, from 25,642 in January to 22,058 in April. The brand's steady ranking within the top 15 highlights its resilience in a competitive market, although the downward trajectory in both ranking and sales suggests potential challenges that may need addressing to regain momentum.
In the Oil category, C Minor made a notable entry into the rankings in March 2026, debuting at 17th place and improving to 14th by April. This upward movement is accompanied by an increase in sales, which rose from 10,599 in March to 13,422 in April, indicating a positive reception of their oil products in Ontario. The absence of C Minor in the top 30 for January and February suggests that the brand has made significant strides in enhancing its market presence in this category. This positive trend in the Oil category could potentially offset some of the declines seen in their Capsules segment, offering a promising avenue for growth and expansion.
Competitive Landscape
In the Ontario capsules market, C Minor has experienced some fluctuations in its ranking and sales performance from January to April 2026. Starting at 11th place in January, C Minor slipped to 12th in February and 13th in March, maintaining this position in April. This downward trend in rank is mirrored by a decrease in sales, from a high in January to a notable dip in April. In comparison, Frank consistently outperformed C Minor, holding the 11th spot for most of the period and showing a strong sales increase in February. Meanwhile, Dosecann and Nutra showed varied performance, with Dosecann slipping to 14th in April and Nutra climbing to 12th, indicating a competitive landscape where C Minor's position is challenged by both upward and downward movements of its competitors. Despite these challenges, C Minor remains a key player in the market, but the brand may need strategic adjustments to regain its higher rank and boost sales.

Notable Products
In April 2026, the top-performing product for C Minor was CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD) in the Capsules category, maintaining its consistent first-place ranking since January, with sales reaching 651 units. The CBD Isolate 100 Max 3000 Oil (30ml) held steady in second place across all months, showing a significant sales increase to 166 units in April. The CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml) remained in third place, with a modest rise in sales figures to 70 units. Meanwhile, CBD 50 Max 3000 Oil Drops (60ml) experienced a slight dip in ranking, falling to fourth place in April after briefly reaching second place in March. These rankings highlight the stability and popularity of C Minor's top products, with only minor shifts observed over the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







